Oramed Pharmaceuticals, Inc. (ORMP)

3.42 +0.03 (+0.88%) USD  |  NASDAQ  |  Apr 02, 16:00
3.42 0.00 (0.00%) Pre-Market: 20:00
More

Oramed Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for ORMP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Lifeward Ltd. Upgrade
Bristol Myers Squibb Co. Upgrade
Merck & Co., Inc. Upgrade
Instil Bio, Inc. Upgrade
Moderna, Inc. Upgrade